The BCGΔBCG1419c Vaccine Candidate Reduces Lung Pathology, IL-6, TNF-α, and IL-10 During Chronic TB Infection

The BCGΔBCG1419c Vaccine Candidate Reduces Lung Pathology, IL-6, TNF-α, and IL-10 During Chronic TB Infection

Mycobacterium tuberculosis (M. tuberculosis), the causative agent of human tuberculosis (TB), is estimated to be harbored by up to 2 billion people in a latent TB infection (LTBI) state. The only TB vaccine approved for use in humans, BCG, does not confer protection against establishment of or react...

Descrición completa

Detalles Bibliográficos
Main Authors: Mario A. Flores-Valdez, César Pedroza-Roldán, Michel de Jesús Aceves-Sánchez, Eliza J. R. Peterson, Nitin S. Baliga, Rogelio Hernández-Pando, JoLynn Troudt, Elizabeth Creissen, Linda Izzo, Helle Bielefeldt-Ohmann, Thomas Bickett, Angelo A. Izzo
Formato: Artigo
Idioma:English
Publicado: Frontiers Media S.A. 2018-06-01
Series:Frontiers in Microbiology
Subjects:
tuberculosis
latent TB infection
BCG
pellicles
biofilms
c-di-GMP
Acceso en liña:https://www.frontiersin.org/article/10.3389/fmicb.2018.01281/full

Internet

https://www.frontiersin.org/article/10.3389/fmicb.2018.01281/full

Títulos similares